Skip to main content
Intended for UK Healthcare Professionals. This website contains promotional content.
Intended for IE Healthcare Professionals. This website contains promotional content.
Report adverse events

Prescribing information, details of adverse event reporting and indications can be found at the bottom of this page. HEPCLUDEX® (bulevirtide)▼ is subject to additional monitoring

LIVER Connect: now available on demand

In the LIVER Connect regular webinars, experts share their innovations and perspectives on hepatitis C and other blood-borne viruses. Initiatives include best practice examples, models of risk reduction and novel ways to test and treat populations that are often difficult to reach. These webinars are a great place to hear about new ideas and approaches, backed by experience and data, that may be applied and adapted for local needs across the country. 

 

You can also register below to attend the live webinars. 

LIVER Connect Meetings

As requested by attendees, a selection of webinars from 2022 onwards are now available to watch on demand

 

You can also register here to attend the live webinars

Sign up now

UKI-EPC-0048

Date of preparation February 2025